Physician profile
Andrew Pugely
NPI 1508185521
$208,213.78
in general payments reported to CMS, 2019-2025
10 companies · $46K in 2025
The $46K reported for 2025 was more than what 86% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $6,156 · 2021: $23K · 2022: $42K · 2023: $37K · 2024: $26K · 2025: $46K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $66K · Consulting Fee: $24K · Travel and Lodging: $16K · Food and Beverage: $3,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $65,975.82 |
| Consulting Fee | $23,520.00 |
| Travel and Lodging | $15,781.72 |
| Food and Beverage | $3,896.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $141,597.31 | 2019-2025 | Si-Lok Select, Si-Lok, Creo S2ai |
| Medtronic, INC. | $45,595.30 | 2021-2025 | Endoskeleton Tc Nanolock Surface Technology, Cd Horizon Spinal System, Infinity Occipitocervical Upper Thoracic System |
| Mirus, LLC | $9,586.67 | 2022-2024 | Europa Pedicle Screw System, Cygnus Anterior Cervical Plate |
| Medtronic USA, INC. | $7,454.93 | 2019-2020 | |
| Smaio Sa | $2,888.47 | 2023 | |
| Nuvasive, INC. | $684.94 | 2019-2022 | |
| Stryker Corporation | $244.13 | 2022-2025 | Mako, Core, Everest Spinal System |
| Bioventus LLC | $118.43 | 2020 | |
| Covis Pharma Gmbh | $28.46 | 2020 | |
| Depuy Synthes Sales INC. | $15.14 | 2025 | Na, Va-Lcp |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Pugely listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.